Biotech stock 2020
Legend Biotech
SOMERSET, N.J.—(BUSINESS WIRE)—August 2, 2020—Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global clinical-stage biopharmaceutical company engaged in the …
Investor Relations - Legend Biotech
The purpose of the Legend Biotech Corporation 2020 Restricted Shares Plan (the “Plan”) is to promote the success and enhance the value of Legend Biotech Corporation, an exempted company …
Investor Overview | XBiotech
Common Stock, no par value (Title of Class of Securities) 98400H102 (CUSIP Number of Class of Securities) John Simard. President and Chief Executive Officer ... 2020, (the “Schedule TO”), relating …
Investor Relations - Adaptive Biotechnologies
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020. The price reported for this transaction is a weighted-average …
Nearby & related entries:
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.